first week on compounded semaglutide (GLP-1) Not my most flattering photos.

Medication adherence also plays a critical role

Natural GLP-1 hormone breaks down within minutes of release

Key Findings So Far While many trials are still enrolling or in early phases, the data that has emerged is encouraging

Still, insurance coverage and cost considerations mean both drugs remain relevant, and patient-centred conversations about therapy choice are critical. GLP-1s beyond weight loss as multi-system therapies Liver disease and metabolic steatohepatitis Non-alcoholic fatty liver disease (NAFLD) and the more severe metabolic dysfunction-associated steatohepatitis (MASH) have few effective pharmacologic treatments

If your appetite is very low, read eating on GLP-1 with a tiny appetite